Natalizumab (originator and biosimilar) for treating highly active relapsing–remitting multiple sclerosis after disease-modifying therapy TA1126 28 January 2026 28 January 2026 Concizumab for treating ...
Don’t miss the latest market commentary from the Farm Futures team. Sign up for the complimentary morning and afternoon market newsletters! Soybeans were having a nice little run over the past seven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results